Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-180756
Filing Date
2025-08-14
Accepted
2025-08-14 15:51:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5621
  Complete submission text file 0001193125-25-180756.txt   6596
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)